Score:
9/15
Analyze what earned this score 🔥
Topper’s Copy
GS2
Governance
15 marks
Despite significant technological and programmatic advancements, India continues to bear the highest global tuberculosis burden. Discuss the key challenges and recent innovations influencing India’s progress toward TB elimination.
Student’s Answer
Evaluation by SuperKalam
Demand of the Question
- Challenges hindering TB elimination progress in India
- Recent innovations and technological advancements in TB control
- Assessment of India's progress toward TB elimination goals
- Forward-looking perspective on elimination prospects
What you wrote:
India accounts for 27% of the global TB burden (Global TB Report 2024). Despite progress under the national TB elimination Program (NTEP) and the government's target of eliminating TB by 2025 by several persistent challenges hamper rapid decline.
[GRAPH: A line graph titled "Fig: Represents increasing cases year by year." The X-axis represents years from 2018 to 2024. The Y-axis has markings from 2.0 to 2.8. The line graph shows data points with corresponding values: "2018" with "21.5 lakh", "2020" with "18.05 lakh", "2021" with "21.35 lakh", "2022" with "24.22 lakh", "2023" with "25.37 lakh", and "2024" with "26.07 lakh". The line shows a dip in 2020 and then a continuous increase.]
India accounts for 27% of the global TB burden (Global TB Report 2024). Despite progress under the national TB elimination Program (NTEP) and the government's target of eliminating TB by 2025 by several persistent challenges hamper rapid decline.
[GRAPH: A line graph titled "Fig: Represents increasing cases year by year." The X-axis represents years from 2018 to 2024. The Y-axis has markings from 2.0 to 2.8. The line graph shows data points with corresponding values: "2018" with "21.5 lakh", "2020" with "18.05 lakh", "2021" with "21.35 lakh", "2022" with "24.22 lakh", "2023" with "25.37 lakh", and "2024" with "26.07 lakh". The line shows a dip in 2020 and then a continuous increase.]
Suggestions to improve:
- Could briefly mention the gap between technological progress and persistent burden to create a stronger problem-solution framework.
What you wrote:
Key challenges:
1. Nearly 35-40% of TB cases are linked to undernutrition
2. Over 50% of TB patients first seek care in private sector with low notification & non-standard treatment
3. India bears 27% of world's MDR-TB cases with treatment success below 60%. long toxic regimes
4. Especially among women, stigma delays diagnosis reduces community reporting & increases treatment interruption.
5. Diabetes, HIV, tobacco use, and alcoholism worsen outcomes. India has one of largest diabetic population.
6. Shortage of trained staff, weak followup. Covid-19 also caused significant notification setback.
Key challenges:
1. Nearly 35-40% of TB cases are linked to undernutrition
2. Over 50% of TB patients first seek care in private sector with low notification & non-standard treatment
3. India bears 27% of world's MDR-TB cases with treatment success below 60%. long toxic regimes
4. Especially among women, stigma delays diagnosis reduces community reporting & increases treatment interruption.
5. Diabetes, HIV, tobacco use, and alcoholism worsen outcomes. India has one of largest diabetic population.
6. Shortage of trained staff, weak followup. Covid-19 also caused significant notification setback.
Suggestions to improve:
- Could enhance the private sector challenge by mentioning specific notification gaps - only 58% of estimated cases are notified annually, creating a significant detection deficit.
- Could elaborate on the healthcare infrastructure challenge by highlighting shortage of over 15,000 TB treatment supporters affecting patient adherence monitoring.
What you wrote:
Recent Innovation:
1. Advanced Diagnostics: Rapid expansion of Truenat, CBNAAT & chest x-Ray AI interpretation (Google-India pilot, 2024) for early case detection
2. Wider use of Bedaquiline, Delamanid & rollout of 6-month BPaL/BPaLM regimen for MDR-TB
3. Strengthen Nikshay, real time tracking & community adoption under Nikshay Mitra (10 lakh+ beneficiary)
4. PM TB mukt Bharat Abhiyan along with nutrition kits and DBT through Nikshay Poshan Yojana.
5. Phase-3 trails of VPM1002 & MIP vaccine with potential rollout by 2026-27.
Recent Innovation:
1. Advanced Diagnostics: Rapid expansion of Truenat, CBNAAT & chest x-Ray AI interpretation (Google-India pilot, 2024) for early case detection
2. Wider use of Bedaquiline, Delamanid & rollout of 6-month BPaL/BPaLM regimen for MDR-TB
3. Strengthen Nikshay, real time tracking & community adoption under Nikshay Mitra (10 lakh+ beneficiary)
4. PM TB mukt Bharat Abhiyan along with nutrition kits and DBT through Nikshay Poshan Yojana.
5. Phase-3 trails of VPM1002 & MIP vaccine with potential rollout by 2026-27.
Suggestions to improve:
- Could strengthen by mentioning Active Case Finding (ACF) campaigns reaching over 50 crore population for early detection.
- Could add the recent 15% funding increase for NTEP in March 2025 and private sector doctor incentives under TB-Mukt Bharat Abhiyan expansion.
- Could include host-directed therapy research currently in clinical trials as an emerging innovation area.
What you wrote:
India's Innovations in diagnostics, drugs, digital tool & community engagement have accelerated TB control. However structural barriers - undernutrition, drug resistance & health system gaps - mean the 2025 target is unlikely but sustained reforms can align India with the 2030 SDG TB elimination goals.
India's Innovations in diagnostics, drugs, digital tool & community engagement have accelerated TB control. However structural barriers - undernutrition, drug resistance & health system gaps - mean the 2025 target is unlikely but sustained reforms can align India with the 2030 SDG TB elimination goals.
Suggestions to improve:
- Could reference specific policy reforms or mention digital governance initiatives like e-Panchayat integration for community-level TB tracking to strengthen the forward-looking vision.
Your answer demonstrates strong analytical skills with excellent use of verified data and comprehensive coverage of both challenges and innovations. The graph integration and balanced assessment of elimination prospects show good understanding of the complex TB landscape in India.
Demand of the Question
- Challenges hindering TB elimination progress in India
- Recent innovations and technological advancements in TB control
- Assessment of India's progress toward TB elimination goals
- Forward-looking perspective on elimination prospects
What you wrote:
India accounts for 27% of the global TB burden (Global TB Report 2024). Despite progress under the national TB elimination Program (NTEP) and the government's target of eliminating TB by 2025 by several persistent challenges hamper rapid decline.
[GRAPH: A line graph titled "Fig: Represents increasing cases year by year." The X-axis represents years from 2018 to 2024. The Y-axis has markings from 2.0 to 2.8. The line graph shows data points with corresponding values: "2018" with "21.5 lakh", "2020" with "18.05 lakh", "2021" with "21.35 lakh", "2022" with "24.22 lakh", "2023" with "25.37 lakh", and "2024" with "26.07 lakh". The line shows a dip in 2020 and then a continuous increase.]
India accounts for 27% of the global TB burden (Global TB Report 2024). Despite progress under the national TB elimination Program (NTEP) and the government's target of eliminating TB by 2025 by several persistent challenges hamper rapid decline.
[GRAPH: A line graph titled "Fig: Represents increasing cases year by year." The X-axis represents years from 2018 to 2024. The Y-axis has markings from 2.0 to 2.8. The line graph shows data points with corresponding values: "2018" with "21.5 lakh", "2020" with "18.05 lakh", "2021" with "21.35 lakh", "2022" with "24.22 lakh", "2023" with "25.37 lakh", and "2024" with "26.07 lakh". The line shows a dip in 2020 and then a continuous increase.]
Suggestions to improve:
- Could briefly mention the gap between technological progress and persistent burden to create a stronger problem-solution framework.
More Challenges
View All- View Challenge
GS3
Science & Technology
14 Jan, 2026
“The recent failures of the PSLV-C61 and PSLV-C62 missions have raised concerns regarding reliability, transparency, and commercial credibility of India’s space launch capabilities.”
In this context, examine the implications of repeated launch vehicle failures on India’s space ecosystem, and discuss the importance of institutional transparency and robust failure analysis mechanisms for sustaining public trust and global competitiveness in the commercial space sector. - View Challenge
GS3
Science & Technology
Yesterday
“Recent advances in CRISPR technology have enabled the reactivation of silenced genes without cutting DNA by targeting epigenetic markers.”
In this context, explain the role of epigenetic gene silencing in human diseases and critically examine how non–DNA-cutting CRISPR approaches could make gene therapy safer and more ethical, with special reference to sickle cell disease. - View Challenge
GS3
Economy
12 Jan, 2026
“Public service broadcasters are increasingly being repositioned as enablers of the creator and orange economy.”
In this context, examine the significance of Prasar Bharati’s ‘Creator’s Corner’ initiative in promoting the creator economy in India. Discuss its potential implications for public broadcasting reforms, digital inclusion, and cultural economy.
